EUCTR2006-006236-22-IT进行中（未招募）不适用
se of Metformin to reduce serum level of Testosterone and improve the metabolic picture in women treated for breast cancer - Metformin and serum Testosterone in women with breast cancer
AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA0 个研究点开始时间: 2010年6月17日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Women with previous surgery for BC, in spontaneous menopause, aged less than 70 years, with serum T level above the median, in one of the following conditions (characterized by endocrine and metabolic stabilization): 1) At least 6 months from surgery in absence of systemic treatment; 2) In therapy with Tamoxifen since at least 6 months with the perspective of prosecute it for at least another year; 3) At least 6 months from the end of chemiotherapy.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previous cardiovascular disease (myocardial infarction, coronary disease, stroke); diabetes ID and NID; use of statins; cotraindications to the use of Metformin, in particular the conditions at risk of lactic acidosis.
研究者
相似试验
已完成
不适用
Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitusNutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusType 1 diabetesISRCTN51650949Scientific and Technological Development Fund (FONDECYT Fondo de Desarrollo Científico y Tecnológico) (Chile)24
已完成
2 期
Metformin in Preventing Androgen Deprivation Therapy Induced Insulin Resistance and Metabolic SyndromeMetabolic SyndromeHypercholesterolemiaNCT01077479Western Sydney Local Health District28
已完成
2 期
Metabolic modulation with metformin to reduce heart failure after acute myocardial infarction: Glycometabolic Intervention as adjunct to Primary percutaneous coronary intervention in ST elevation myocardial infarction (GIPS-III)Heart FailureNL-OMON39113niversitair Medisch Centrum Groningen380
进行中（未招募）
不适用
Metabolic modulation with metformin to reduce heart failure after acute myocardial infarction: Glycometabolic Intervention as adjunct to Primary percutaneous coronary intervention in ST elevation myocardial (GIPS-III) - GIPS-IIIpreservation and remodeling of the left ventricles after acute myocardial infarctionEUCTR2009-018162-34-NLThorax Center, Univeristy Medical Center Groningen, Groningen, The Netherlands
已完成
1 期
The effect of metformin on thyroid noduleThyroid nodule.Nontoxic single thyroid noduleIRCT2016022325895N3Vice chancellor for research, Arak University of Medical Sciences240